Vladimir Dimitrov, CFA is a former strategy consultant within the field of brand and intangible assets valuation. During his career in the City of London he has been working with some of the largest global brands within the technology, telecom and banking sectors. He graduated from the London School of Economics and is interested in finding reasonably priced businesses with sustainable long-term competitive advantages.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of t ...

SHANGHAI, Nov. 26, 2025 /PRNewswire/ -- Four Seasons Education (Cayman) Inc. ("Four Seasons Education" or the "Company") (NYSE: FEDU), a tourism and education-related service provider in China, today announced that it will report its unaudited financial results for the first half of fiscal year 2026 ended August 31, 2025, on December 2, 2025, before the open of U.S. markets. Accessibility StatementSkip Navigation The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on ...

The Kroger Co. ( KR ) is one of the largest grocery retailers in the US, with a significant store footprint and well-known private label brands. With the company developing well despite the competitiveAs of 2025, I've got over 10 years of researching companies. In total, throughout my investing life, I estimate that I researched (in depth) well over 1000 companies, from commodities like oil, natural gas, gold and copper to tech like Google or Nokia and many emerging market stocks, which I believe could help ...

Small deep value individual investor, with a modest private investment portfolio, split approx. 50%-50% between shares and call options. I have a B.Sc. in aeronautical engineering and over 6 years of experience as an engineering consultant in the aerospace sector. The latter statement is not relevant in any way whatsoever to my investment style, but I thought to add it for self-indulgent purposes. I have a contrarian investment style, highly risky, and often dealing with illiquid options. How illiquid? Well ...

U.S. stock futures pointed to a higher open following the prior session's broad-based gains, as delayed data boosts expectations for a Fed rate cut next month. ...

This rookie ETF could be a multiyear winner if analyst Dan Ives is right in his assessments of how the AI trend will play out. Especially in the realm of widely followed growth stocks, some sell-side analysts develop cult-like followings. That status isn't cultivated via perfect track records, because no one gets it right all the time, but some analysts ascend to that rarefied territory by being correct more often than not. For some investors, Wedbush's Dan Ives is that analyst in the artificial intelligenc ...

It might not be as good as you think over many years. Macy's (M +9.14%) is an iconic department store chain that has been around since 1858. It has stood the test of time, but it's been struggling over the past few years. Let's check out where it stands today and how its stock has performed for shareholders. What's happening at Macy's Macy's sales continue to decline as the American retail landscape shifts. The huge department store of the past has morphed into boutique experiences, designer stores, and, mo ...

Core Insights - Dell has emerged as a significant player in the AI sector, yet its stock performance has been volatile, fluctuating despite its successes in the AI space [1] Group 1: Company Performance - Dell's stock has shown a pattern of ups and downs, indicating market uncertainty despite its recognition as an AI-winner [1] Group 2: Investment Perspective - The focus on sustained profitability, characterized by strong margins, stable and expanding free cash flow, and high returns on invested capital, is emphasized as a more reliable driver of returns than valuation alone [1]

The current White House National Economic Council Director is in tune with Trump's view on interest rates ...

The weight loss drug market may approach almost $100 billion by the end of the decade.The words "Ozempic" and "Wegovy" almost have become household names as these products have changed the lives of many – from our own friends and family to celebrities. These drugs, prescribed for weight loss, have been in high demand, and this has driven revenue of drugmaker Novo Nordisk (NVO +4.65%) higher over time.But in recent quarters, Novo has lost some ground to rival Eli Lilly, the maker of Mounjaro and Zepbound -- ...